Perrigo Company PLC (NYSE:PRGO)
| 42.79 Delayed Data As of 4:15pm ET |  +0.03 / +0.07%Today’s Change | 38.20 Today|||52-Week Range 49.91 | -4.32% Year-to-Date |
Latest PRGO News | Press Releases
| Why Is Perrigo (PRGO) Up 7.1% Since Last Earnings Report? Sep 10 / Zacks.com - Paid Partner Content | Perrigo (PRGO) to Acquire Another Self-Care Company HRA Pharma Sep 09 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 42.76 |
| Today’s open | 42.90 |
| Day’s range | 42.73 - 43.23 |
| Volume | 956,861 |
| Average volume (3 months) | 1,706,384 |
| Market cap | $5.9B |
Data as of 4:15pm ET, 09/22/2021
Growth & Valuation
| Earnings growth (last year) | -211.21% |
| Earnings growth (this year) | -38.31% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +4.67% |
| P/E ratio | NM |
| Price/Sales | 1.20 |
| Price/Book | 1.03 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ALLKAllakos Inc | +0.14 | +0.13% |
| IONSIonis Pharmaceutical... | +0.28 | +0.77% |
| ---- | ||
| RAREUltragenyx Pharmaceu... | +0.49 | +0.51% |
Data as of 4:14pm ET, 09/22/2021
Financials
| Next reporting date | November 11, 2021 |
| EPS forecast (this quarter) | $0.67 |
| Annual revenue (last year) | $5.1B |
| Annual profit (last year) | -$162.6M |
| Net profit margin | -3.21% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
